Abstract
Market Highlights
Understand the European interventional cardiology (IC) market, covering Europe
i (including France, Germany, Italy, Scandinavia, Spain, Switzerland, and the
United Kingdom) and Europe ii (Benelux [Belgium, the Netherlands, and
Luxembourg]). See how late stent thrombosis concerns in drug-eluding (DES) are
bolstering bare-metal stent (BMS) usage. Discover how the release of new DES
in Europe is driving unit usage. See why the emergence of newer technologies
in the European IC market is enabling physicians to treat more complex cases,
driving procedural growth.
View Cart
